Savior LLC Abb Vie Inc. Transaction History

Savior LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 12, 2022	SELL	$131.98 - $163.75 $9,766 - $12,117	-74 Reduced 27.01%	200 $33,000
Q4 2021 Feb 03, 2022	BUY	$107.43 - $135.93 $4,404 - $5,573	41 Added 17.6%	274 $37,000
Q3 2021 Oct 05, 2021	SELL	$106.4 - $120.78 $28,728 - $32,610	-270 Reduced 53.68%	233 $25,000
Q4 2020 Feb 02, 2021	BUY	$80.49 - $108.67 $80 - $108	1 Added 0.2%	503 $54,000
Q2 2020 Jul 28, 2020	SELL	$73.37 - $98.18 $7,337 - $9,818	-100 Reduced 16.61%	502 $49,000
Q1 2020 Apr 22, 2020	BUY	$64.5 - $97.79 $258 - $391	4 Added 0.67%	602 $46,000
Q4 2019 Jan 22, 2020	BUY	$72.13 - $90.25 $43,133 - $53,969	598 New	598 $53,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Savior LLC, based on Form 13F filings with the SEC.

Stay updated on Savior LLC with notifications on news.